Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
This study is assess the safety and performance of the Neurotronic Infusion catheter for treatment of patients with Type 2 Diabetes (T2DM) and hypertension.
Age ≥ 21 and ≤ 65 years at time of enrollment. [+13]
T1DM or poorly controlled T2DM (defined as HbA1c > 9.0% or use insulin as medica... [+58]